scholarly journals The role of childhood abuse in HPA-axis reactivity in Social Anxiety Disorder: A pilot study

2010 ◽  
Vol 83 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Bernet M. Elzinga ◽  
Philip Spinhoven ◽  
Ed Berretty ◽  
Paula de Jong ◽  
Karin Roelofs
2013 ◽  
Vol 38 (2) ◽  
pp. 226-238 ◽  
Author(s):  
Anu Asnaani ◽  
Mike Rinck ◽  
Eni Becker ◽  
Stefan G. Hofmann

Author(s):  
Esmail Soltani ◽  
◽  
Seyed Abdolmajid Bahrainian ◽  
Ali Farhoudian ◽  
Abbas Masjedi Arani ◽  
...  

Objectives: The purpose of the current study was to examine the effectiveness of ACT on symptom severity, fear about negative evaluation, quality of life and mediation role of acceptance, cognitive fusion and value among patients with Social Anxiety Disorder (SAD). Methods: Thirty patients diagnosed with SAD were randomized in the intervention (n=15) or waiting list groups (n=15). The Social Phobia and Anxiety Inventory (SPAI), Brief Fear of Negative Evaluation Scale (BFNE), WHO Quality of Life (WHOQOL), Social Anxiety - Acceptance and Action Questionnaire (SA-AAQ), Cognitive Fusion Questionnaire (CFQ) and Valued Living Questionnaire (VLQ) were administered before, immediately after, and at one month follow up. Repeated measurement design was used in the intervention group to investigate the changes of mediation and outcomes variables in the pretest, during, and post- therapy. Twenty-four patients completed the study. One-way analysis of covariance, Multivariate analysis of covariance and repeated measures was used for analysis. Results: Results showed that there were differences between the intervention and waiting list groups on the severity of symptoms (p=0.001), fear of negative evaluation (p=0.002), and quality of life (p=0.03), as well as in terms of specific measures of SA-AAQ(p=0.001), cognitive fusion (p=0.001), and important section of VLQ(p=0.001). Repeated measurement result showed that acceptance and action of social anxiety and cognitive fusion had a mediating role in the severity of anxiety, fear about negative evaluation, and quality of life. Discussion: Results of the study indicate the effectiveness of ACT for SAD and highlighted mediator contribution acceptance and action and cognitive fusion in severity of social anxiety.


CNS Spectrums ◽  
2002 ◽  
Vol 7 (9) ◽  
pp. 655-657 ◽  
Author(s):  
Naomi M. Simon ◽  
Nicole B. Korbly ◽  
John J. Worthington ◽  
Gustavo Kinrys ◽  
Mark H. Pollack

ABSTRACTThere is limited systematic data assessing alternate pharmacotherapy of social anxiety disorder in patients failing to tolerate or fully respond to initial treatment; no data specifically address the efficacy of citalopram in this scenario. We present a prospective open-label trial of citalopram in 10 patients with generalized social anxiety disorder, 6 of 10 of whom had not responded to or not tolerated a prior treatment intervention for the disorder. Citalopram, at a mean dose of 55 mg (SD+12.7 mg) was well tolerated, and patients improved significantly on all outcome measures. Results of this study suggest that citalopram may be a safe and effective treatment for generalized social anxiety disorder, including patients who have failed to tolerate or respond to a prior treatment trial.


EXPLORE ◽  
2020 ◽  
Author(s):  
Dr Jitender Jakhar ◽  
Mr Anantha Krishna ◽  
Dr Hemant Bhargav ◽  
Dr Shivarama Varambally

2015 ◽  
Vol 34 (1) ◽  
pp. 1-27 ◽  
Author(s):  
Gentiana Sadikaj ◽  
D. S. Moskowitz ◽  
Jennifer J. Russell ◽  
David C. Zuroff

2017 ◽  
Vol 52 ◽  
pp. 79-87 ◽  
Author(s):  
Jonah N. Cohen ◽  
Deborah A.G. Drabick ◽  
Carlos Blanco ◽  
Franklin R. Schneier ◽  
Michael R. Liebowitz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document